BSX vs UNMA · P/E 20, rev $10.65B vs P/E 4.6, $5.35B cap
Boston Scientific Corp (BSX) versus Unum Group 6.250% JR NT58 (UNMA) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Unum Group 6.250% JR NT58 (UNMA) common stock listed on NYSE.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
UNMA does not have a complete income-statement cache yet.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. UNMA currently screens at market cap $5.35B and trailing P/E 4.6.
Not investment advice. Open the BSX and UNMA stock pages for the full models.
Not investment advice.